The experience with Brentuximab vedotin in the treatment of lymphomatoid papulosis in a pediatric patient-Reference-Cited by-同舟云学术

The experience with Brentuximab vedotin in the treatment of lymphomatoid papulosis in a pediatric patient

Published:2024-03-19 Issue:1 Volume:69 Page:121-131
ISSN:2411-3042
Container-title:Russian journal of hematology and transfusiology
language:
Short-container-title:Gematologiâ i transfuziologiâ

Author:

Volkova A. S.¹^ORCID,Valiev T. T.²^ORCID,Kovrigina A. M.³^ORCID,Belysheva T. S.¹^ORCID,Varfolomeeva S. R.¹

Affiliation:

1. N.N. Blokhin National Medical Research Centre of Oncology

2. N.N. Blokhin National Medical Research Centre of Oncology; Sechenov First Moscow State Medical University (Sechenov University)

3. National Medical Research Center for Hematology

Publisher

National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation

Reference44 articles.

1. Macaulay W.L. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant. Arch Dermatol. 1968; 97(1): 23–30. DOI: 10.1001/archderm.97.1.23.

2. Willemze R., Meyer C.J., Van Vloten W.A., Scheffer E. The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol. 1982; 107(2): 131– 44. DOI: 10.1111/j.1365-2133.1982.tb00331.x.

3. Martinez-Cabriales S.A., Walsh S., Sade S., Shear N.H. Lymphomatoid papulosis: an update and review. J Eur Acad Dermatol Venereol. 2020; 34(1): 59–73. DOI: 10.1111/jdv.15931.

4. Schiemann W.P., Pfeifer W.M., Levi E., et al. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous Tcell lymphoma. Blood. 1999; 94: 2854–61.

5. Haro R., Juarez A., Diaz J.L., et al. Regional lymphomatoid papulosis of the breast restricted to an area of prior radiotherapy. Cutis. 2016; 97: E15–9.